↓ Skip to main content

Assessment of circulating tumor cells and serum markers for progression-free survival prediction in metastatic breast cancer: a prospective observational study

Overview of attention for article published in Breast Cancer Research, February 2012
Altmetric Badge

Citations

dimensions_citation
72 Dimensions

Readers on

mendeley
87 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Assessment of circulating tumor cells and serum markers for progression-free survival prediction in metastatic breast cancer: a prospective observational study
Published in
Breast Cancer Research, February 2012
DOI 10.1186/bcr3114
Pubmed ID
Authors

François-Clément Bidard, David Hajage, Thomas Bachelot, Suzette Delaloge, Etienne Brain, Mario Campone, Paul Cottu, Philippe Beuzeboc, Emilie Rolland, Claire Mathiot, Jean-Yves Pierga

Abstract

Circulating tumor cells (CTC) have been recently proposed as a new dynamic blood marker whose positivity at baseline is a prognostic factor and whose changes under treatment are correlated with progression-free survival (PFS) in metastatic breast cancer patients. However, serum marker levels are also used for the same purpose, and no clear comparison has been reported to date.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 87 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 2%
Netherlands 1 1%
Turkey 1 1%
Saudi Arabia 1 1%
Kenya 1 1%
Unknown 81 93%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 20 23%
Researcher 17 20%
Student > Master 8 9%
Student > Postgraduate 7 8%
Student > Doctoral Student 6 7%
Other 18 21%
Unknown 11 13%
Readers by discipline Count As %
Medicine and Dentistry 32 37%
Agricultural and Biological Sciences 16 18%
Biochemistry, Genetics and Molecular Biology 10 11%
Engineering 4 5%
Nursing and Health Professions 3 3%
Other 4 5%
Unknown 18 21%